Le alterazioni elettrocardiografiche espressione di cardiotossicità

Maria Cristina Lombari; Carlo Gabriele Tocchetti; Carmela Coppola; Angelo Sabato Boccia; Nicola Maurea

doi:10.1016/j.jcecho.2011.04.002

Le alterazioni elettrocardiografiche espressione di cardiotossicità

Translated title of the contribution: Electrocardiographic changes: Expression of cardiotoxicity

Maria Cristina Lombari, Carlo Gabriele Tocchetti, Carmela Coppola, Angelo Sabato Boccia, Nicola Maurea

Istituto Nazionale Tumori Fondazione G. Pascale

Research output: Contribution to journal › Article › peer-review

Abstract

As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.

Translated title of the contribution	Electrocardiographic changes: Expression of cardiotoxicity
Original language	Italian
Pages (from-to)	55-59
Number of pages	5
Journal	Journal of Cardiovascular Echography
Volume	21
Issue number	2
DOIs	https://doi.org/10.1016/j.jcecho.2011.04.002
Publication status	Published - 2011

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.jcecho.2011.04.002

Cite this

@article{d60c3a85a82d4f8db3a5189927fa65cf,

title = "Le alterazioni elettrocardiografiche espressione di cardiotossicit{\`a}",

abstract = "As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.",

keywords = "Antineoplastic treatments, Arrhythmias, Cardiotoxicity, QT prolongation, Target therapy",

author = "Lombari, {Maria Cristina} and Tocchetti, {Carlo Gabriele} and Carmela Coppola and Boccia, {Angelo Sabato} and Nicola Maurea",

year = "2011",

doi = "10.1016/j.jcecho.2011.04.002",

language = "Italian",

volume = "21",

pages = "55--59",

journal = "Journal of Cardiovascular Echography",

issn = "2211-4122",

publisher = "Elsevier Limited",

number = "2",

}

TY - JOUR

T1 - Le alterazioni elettrocardiografiche espressione di cardiotossicità

AU - Lombari, Maria Cristina

AU - Tocchetti, Carlo Gabriele

AU - Coppola, Carmela

AU - Boccia, Angelo Sabato

AU - Maurea, Nicola

PY - 2011

Y1 - 2011

N2 - As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.

AB - As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.

KW - Antineoplastic treatments

KW - Arrhythmias

KW - Cardiotoxicity

KW - QT prolongation

KW - Target therapy

UR - http://www.scopus.com/inward/record.url?scp=80052829331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052829331&partnerID=8YFLogxK

U2 - 10.1016/j.jcecho.2011.04.002

DO - 10.1016/j.jcecho.2011.04.002

M3 - Articolo

AN - SCOPUS:80052829331

VL - 21

SP - 55

EP - 59

JO - Journal of Cardiovascular Echography

JF - Journal of Cardiovascular Echography

SN - 2211-4122

IS - 2

ER -

Le alterazioni elettrocardiografiche espressione di cardiotossicità

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this